NCT03667235

Brief Summary

To compare mechanic and thermic stability of pericardium fixated either with 0.6% glutaraldehyde for 10 minutes or with 0.6% glutaraldehyde for 20 minutes

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Aug 2017

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 4, 2017

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

September 10, 2018

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 12, 2018

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2019

Completed
Last Updated

December 10, 2019

Status Verified

December 1, 2019

Enrollment Period

2.2 years

First QC Date

September 10, 2018

Last Update Submit

December 9, 2019

Conditions

Keywords

OZAKI technique

Outcome Measures

Primary Outcomes (2)

  • mechanic stability tests to investigate uniaxial and cyclical tensile properties

    mechanical tests include the use of a universal test machine (MTS Bionix, Department of Bioengineering of Universitaetsspital Basel) for: * uniaxial ultimate tensile strength (UTS) test; * cyclical tensile stretching of the tissue in order to investigate its viscoelastic properties

    4 days after surgery

  • thermic stability by using constant force at linearly increasing temperature

    constant force at linearly increasing temperature: Thermal stability tests will be conducted on 20 x 4 mm stripes by the imposition of a constant load (approximately 1N) submerged in a saline-solution bath. The temperature of the bath will be increased at a rate of approximately 2.5-5 °C/min, and the sample cross-section will be measured by means of a high-resolution camera (Canon EOS, Japan)

    4 days after surgery

Secondary Outcomes (2)

  • histologic analysis of collagen fiber organization and quantification

    4 days after surgery

  • Pronase testing to analyse enzymatic degradation

    4 days after surgery

Interventions

10 versus 20 minutes treatment of human pericardium with 0.6% glutaraldehyde in OZAKI procedure

10 versus 20 minutes treatment of human aortic valve tissue with 0.6%glutaraldehyde

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

patients undergoing aortic valve surgery with OZAKI technique at Universitätsspital Basel/ Switzerland

You may qualify if:

  • patients undergoing aortic valve surgery with sufficient leftover tissues from the OZAKI procedure (excess of pericardium and calcified aortic valve leaflets)

You may not qualify if:

  • denial of consent
  • insufficient leftover tissues from the OZAKI procedure
  • patients after thoracic radiation or surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Herzchirurgie University Hospital Basel

Basel, 4031, Switzerland

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Leftover tissues from the OZAKI procedure (excess of pericardium and calcified aortic valve leaflets) will be fixed in glutaraldehyde in the operation room and stored in sterile tubes in Phosphate Buffered Saline(PBS) and transferred at room temperature to the lab where it will be stored in a lab fridge at 4°C.

MeSH Terms

Interventions

Glutaral

Intervention Hierarchy (Ancestors)

AldehydesOrganic Chemicals

Study Officials

  • Oliver Reuthebuch, PD Dr. med

    University Hospital, Basel, Switzerland

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 10, 2018

First Posted

September 12, 2018

Study Start

August 4, 2017

Primary Completion

October 31, 2019

Study Completion

October 31, 2019

Last Updated

December 10, 2019

Record last verified: 2019-12

Locations